Cite Filings / STOK / 0001193125-21-202384
Feed Companies Filings Check
Sign in
SC 13D/A

Beneficial Ownership Report

Stoke Therapeutics, Inc. · Filed 2021-06-29 · Acc 0001193125-21-202384

Documents 1

  • SC 13D/A Beneficial Ownership Report , d126894dsc13da.htm

Around this filing

  • 2024-04-18 SC 13D/A Beneficial Ownership Report
  • 2021-07-02 4 COO & CBO sold 5,700 shares at $33.33 ($189,987)
  • 2021-06-30 SC 13D Beneficial Ownership Report
  • 2021-06-30 3 Initial Statement of Ownership
  • 2021-06-30 4 10% owner disposed of 17,161,713 shares (other)
  • 2021-06-29 SC 13D/A Beneficial Ownership Report
  • 2020-11-27 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 9.9%
  2. 2026-11-16 SCHEDULE 13G/A · Baker Bros. Advisors LP 4.7%
  3. 2026-11-16 SCHEDULE 13G/A · Wellington Management Group LLP 7.3%
  4. 2026-11-13 SCHEDULE 13G/A · Morgan Stanley 4.9%
Loading d126894dsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…